Macro Group Pharmaceuticals (Macro Capital) S.A.E

E£1.32As of Sun 8 Nov 2026, 12:00 UTC
EGX:MCROConsumer Staples
Country Egypt
PE (Fwd) •••
TSR 5Y CAGR 13.05%
Div yield 8.09%
ROE 27.11%
Perfumes, Cosmetics, and Other Toilet Preparations
Beta (5Y) 0.21
PE TTM 16.87
TSR TTM 66.72%
Mkt cap E£4.516B
ROIC 33.97%
SE Grade™
Value
Quality
Moat
Consensus
Reference
E£1.34
1.70%
68.58%
Hold 11|7|6|9|11
4Q25
1Q26
2Q26
3Q26
Earnings per shareE£
0.01
0.01
0.01
0.01
3.25%
7.27%
12.90%
5.93%
RevenueE£M
255.7
260.1
258.6
255.0
11.86%
9.92%
9.01%
3.72%
Peers (US$85.10M)
Cap (US$)
PE
84.25M
102.2x
71.63M
8.625x
85.78M
4.465x
Capital
TTM
5Y
10Y
Leveragex
0.390
0.170
0.175
EBIT/Intx
0.699
0.268
0.268
Own earn%
(52.53)
(37.70)
(29.82)
Sh yield%
51.36
35.78
36.10
Owners
Insiders/Inst%
11.97
46.07
Short interest%
1.44
SBC / revenue%
5.24
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
13–20
$1 testx
—
Incr. ROIC%
4